Sangamo BioSciences | Creditori Commerciali



Trade Creditors Cambiamento Data
Alaunos Therapeutics USD 516K 58K 2024-12
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Bayer EUR 6.59B 931M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Cipla INR 28.37B 1.62B 2025-03
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 1.84M 540K 2024-12
CSL USD 2.98B 2.11B 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Grifols EUR 852.3M 25.42M 2024-12
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
J&J USD 9.54B 766M 2025-03
Merck USD 3.78B 295M 2025-03
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Tectonic Therapeutic USD 976K 1.66M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Sangamo BioSciences Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.